Studies on the development of resistance to the pure antiestrogen Faslodex™ in three human breast cancer cell lines
Authors:
- 27 May 2003
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 85 (1) , 33-47
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Exploring the new world of the genome with DNA microarraysNature Genetics, 1999
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- The future of antihormone therapy: innovations based on an established principleJournal of Cancer Research and Clinical Oncology, 1996
- Short-term effects of pure anti-oestrogen ICI 182780 treatment on oestrogen receptor, epidermal growth factor receptor and transforming growth factor-alpha protein expression in human breast cancerEuropean Journal of Cancer, 1996
- Effects of short-term antiestrogen treatment of primary breast cancer on estrogen receptor mRNA and protein expression and on estrogen-regulated genesBreast Cancer Research and Treatment, 1996
- Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivityEuropean Journal of Cancer, 1993
- Antiestrogen Resistance: Mechanisms by Which Breast Cancer Cells Undermine the Effectiveness of Endocrine TherapyJNCI: Journal of the National Cancer Institute, 1991
- Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell linesThe Journal of Steroid Biochemistry and Molecular Biology, 1989
- Novel antioestrogens without partial agonist activityJournal of Steroid Biochemistry, 1988
- Establishment and characterization of a cell line of human breast carcinoma origin1979